Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
Jose Reyes, Isabella S. Del Priore, Andrea C. Chaikovsky…·Scott W. Lowe
In mouse pancreatic cancer models, p53, CDKN2A and SMAD4 programs converge on a rare Kras-mutant progenitor-like state whose niche KRAS inhibition collapses and p53 loss expands.